SightfileU.S. market data from official filings

Companies › OCUL

OCULAR THERAPEUTIX INC (OCUL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001393434 · EDGAR filings · Updated 2026-06-18

OCULAR THERAPEUTIX INC (OCUL) has reported institutional ownership of 94.4%, with 267 institutional managers holding positions valued at $1.77B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
94.4%
Institutional managers
267
Reported 13F value
$1.77B
Insider activity
54 trans.
−$2.89M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OCULAR THERAPEUTIX INC has 267 institutional holders and institutional ownership of 94.4%.

Insider activity

Insiders reported 54 transactions (2 buys, 29 sells) across 17 reporting insiders, with a net reported value of −$2.89M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2020-11-05 (recurring since 2020-03-12) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ADDUS HOMECARE CORP COM (ADUS) · ANI PHARMACEUTICALS INC (ANIP) · VERICEL CORP COM (VCEL) · PEDIATRIX MEDICAL GROUP INC (MD) · ZYMEWORKS INC (ZYME) · INNOVIVA INC (INVA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-18.